David F Hale is of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 714 shares of ONCT, which is worth approximately $806. The most recent transaction as insider was on Feb 23, 2024, when has been sold 714 shares (Common Stock) at a price of $9.04 per share, resulting in proceeds of $6,454. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 714
0% 3M change
n/a 12M change
Total Value Held $806

DAVID F HALE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2024
BUY
Open market or private purchase
$6,454 $9.04 p/Share
714 Added 50.0%
714 Common Stock

Also insider at

BIOC
BIOCEPT INC Healthcare
DRMA
Dermata Therapeutics, Inc. Healthcare
DFH

David F Hale

San Diego, CA

Track Institutional and Insider Activities on ONCT

Follow Oncternal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONCT shares.

Notify only if

Insider Trading

Get notified when an Oncternal Therapeutics, Inc. insider buys or sells ONCT shares.

Notify only if

News

Receive news related to Oncternal Therapeutics, Inc.

Track Activities on ONCT